SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-22-010045
Filing Date
2022-09-30
Accepted
2022-09-30 16:30:17
Documents
1
Period of Report
2022-09-28

Document Format Files

Seq Description Document Type Size
1 form4-09302022_040901.html 4  
1 form4-09302022_040901.xml 4 5508
  Complete submission text file 0001415889-22-010045.txt   6943
Mailing Address 1040 SPRING ST SILVER SPRING MD 20910
Business Address 1040 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS Corp (Issuer) CIK: 0001082554 (see all company filings)

IRS No.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O UNITED THERAPEUTICS CORPORATION 1040 SPRING STREET SILVER SPRING MD 20910
Business Address
Mesa Nilda (Reporting) CIK: 0001756697 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-26301 | Film No.: 221284445